Stocks dip as earnings pour in, consumer discretionary lags

BTIG Reaffirms Celgene (CELG) at 'Buy'; Q3 Results, Update Bolster Confidence

BTIG affirms Celgene Corporation (Nasdaq: CLEG) at Buy with a price target of $138 following Q3 results and update.

The firm commented today: Full-year 2016 EPS guidance moved up +$0.17 at the midpoint, above the +$0.10 3Q16 EPS beat, and highlighted Sales and EPS for... More

SunTrust Robinson Humphrey Remains Sidelined on Amazon.com (AMZN); Reiterates $850 Price Target

SunTrust Robinson Humphrey reiterated a Hold rating and $850.00 price target on Amazon.com (NASDAQ: AMZN) following the company's 3Q earnings report. Incremental margins for 3Q were just 2% on a consolidated basis. Retail incremental margins were -2% as North American margins expanded just 20bps and... More

Baird Reiterates Buy on Amazon.com (AMZN) Following 3Q

Baird reiterated an Outperform rating and $850.00 price target on Amazon.com (NASDAQ: AMZN) following the company's 3Q earnings report. AMZN reported revenues of $32.7B, above Baird's expectations and in-line with consensus. 4Q16 revenue guidance of $42B-$45.5B was in-line with consensus of $44.6B,... More

Wedbush Remains Bullish on Amazon.com (AMZN) Following 3Q

Wedbush reiterated an Outperform rating and $900.00 price target on Amazon.com (NASDAQ: AMZN) following the company's 3Q earnings report. Revenue was $32.71 billion vs. the consensus of $32.69 billion, and guidance of $31.0 33.5 billion. EPS was $0.52 vs. the consensus of $0.78. 2016 EPS estimate were reduced to $5.06 from $6.00 prior, and operating income to $1.26 billion... More

Needham & Company Remains Sidelined on Amazon.com (AMZN) Following Mixed 3Q

Needham & Company reiterated a Hold rating on Amazon.com (NASDAQ: AMZN) following the company's 3Q earnings report. AMZN reported revenue of $32.7B, in-line with consensus. CSOI margin, or non-GAAP operating income margin was 4.2%, increasing y/y from 3.9%, but decreasing q/q from 6.9%, a significant... More

Jefferies Raises Price Target on Bristol-Myers Squibb (BMY) Following 3Q

Jefferies reiterated a Hold rating on Bristol-Myers Squibb Co. (NYSE: BMY), and raised the price target to $58.00 (from $54.00), following the company's 3Q. Non-GAAP operating expenses are now expected to be roughly flat through 2020, relative to 2016 levels as part of the company's plan... More

Jefferies Reiterates Buy on Amazon.com (AMZN) Following Mixed Quarter

Jefferies reiterated a Buy rating and $950.00 price target on Amazon.com (NASDAQ: AMZN) following the company's 3Q earnings report. Net sales were up 29% Y/Y to $32.71B vs the Street's $32.69B. EPS of $0.52 came in below consensus at $0.77. 4Q guidance was below... More

RBC Capital Reiterates Outperform on Alphabet (GOOGL) Following 3Q Beat

RBC Capital reiterated an Outperform rating and $1025.00 price target on Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) following the company's 3Q earnings report. Gross revenue of $22.5B was about 2% above the Street at $22.0B, with the beat primarily coming... More